No 13F manager has reported this stock in the last 8 quarters.
None.
None.
No insider has filed a notice of proposed sale (Form 144) for HeartSciences Inc in the last 12 months.
No 13F manager reports holding HSCS.
| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VE
Vanguard Index Funds
|
$22.4K | 191.5K | 3.99% | 0.00% | March 31, 2024 |
|
FE
Fidelity Concord Street Trust
|
$4.99K | 42.3K | 0.88% | 0.00% | February 29, 2024 |
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DC
Digital Currency Group, Inc.
5%+ holder
13D · 9.4%
|
411.5K | 8.57% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
AS
Andrew Simpson
5%+ holder
13D · 7.5%
|
403.7K | 8.41% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
1 more holders behind a free account
See every insider and 5%+ holder of HeartSciences Inc.
Sign up freeLoading...